Whole-genome characterization of chemoresistant ovarian cancer. LHS Patch AM, Christie EL, Etemadmoghadam D, Garsed DW, George J, Fereday S ... Nature 521 (7553), 489-94, 2015 | 1600 | 2015 |
Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial M Janda, V Gebski, LC Davies, P Forder, A Brand, R Hogg, TW Jobling, ... Jama 317 (12), 1224-1233, 2017 | 450 | 2017 |
Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis NA Lokman, ASF Elder, C Ricciardelli, MK Oehler International journal of molecular sciences 13 (8), 9959-9970, 2012 | 449 | 2012 |
Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial M Janda, V Gebski, A Brand, R Hogg, TW Jobling, R Land, T Manolitsas, ... The lancet oncology 11 (8), 772-780, 2010 | 423 | 2010 |
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22. 2 H Song, SJ Ramus, J Tyrer, KL Bolton, A Gentry-Maharaj, E Wozniak, ... Nature genetics 41 (9), 996-1000, 2009 | 349 | 2009 |
The role of annexin A2 in tumorigenesis and cancer progression NA Lokman, MP Ween, MK Oehler, C Ricciardelli Cancer Microenvironment 4, 199-208, 2011 | 303 | 2011 |
Common variants at 19p13 are associated with susceptibility to ovarian cancer KL Bolton, J Tyrer, H Song, SJ Ramus, M Notaridou, C Jones, T Sher, ... Nature genetics 42 (10), 880-884, 2010 | 300 | 2010 |
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. WAH Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA ... Endocrine Related Cancer 20 (2), 251-62, 2013 | 297 | 2013 |
Menorrhagia: an update MK Oehler, MCP Rees Acta obstetricia et gynecologica Scandinavica 82 (5), 405-422, 2003 | 262 | 2003 |
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. TN Kondrashova O, Topp M, Nesic K, Lieschke E, Ho GY, Harrell MI, Zapparoli ... Nature Communications 28 (9(1)), 3970, 2018 | 261* | 2018 |
Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 … DD Buchanan, YY Tan, MD Walsh, M Clendenning, AM Metcalf, ... Journal of Clinical Oncology 32 (2), 90-100, 2014 | 258 | 2014 |
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. BMJ Helland Å, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM ... PLoS One. 6 (4), e18064, 2011 | 231 | 2011 |
Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. WPM Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, ... Cancer Causes Control 21 (12), 2303-8, 2010 | 227 | 2010 |
Endometrial cancer AJ Ryan, B Susil, TW Jobling, MK Oehler Cell and tissue research 322, 53-61, 2005 | 214 | 2005 |
Risk factors associated with preterm (< 37+ 0 weeks) and early preterm birth (< 32+ 0 weeks): univariate and multivariate analysis of 106 345 singleton births from the 1994 … JA Martius, T Steck, MK Oehler, KH Wulf European Journal of Obstetrics & Gynecology and Reproductive Biology 80 (2 …, 1998 | 198 | 1998 |
The Role of ABC Transporters in Ovarian Cancer Progression and Chemoresistance CR M.P. Ween, M.A. Armstrong, M.K. Oehler Critical Reviews in Oncology/Hematology, 2015 | 197 | 2015 |
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer KM Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek ... Nature Communications 4, 1628, 2013 | 190 | 2013 |
Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density S Hague, L Zhang, MK Oehler, S Manek, IZ MacKenzie, R Bicknell, ... Clinical cancer research 6 (7), 2808-2814, 2000 | 180 | 2000 |
Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth MK Oehler, C Norbury, S Hague, MCP Rees, R Bicknell Oncogene 20 (23), 2937-2945, 2001 | 163 | 2001 |
The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells S Kamitani, M Asakawa, Y Shimekake, K Kuwasako, K Nakahara, ... FEBS letters 448 (1), 111-114, 1999 | 162 | 1999 |